The Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in Pharmacovigilance (READUS-PV) is an international collaborative which aim at developing the first reporting recommendations for studies using disproportionality analyses in databases of spontaneously reported adverse events. 

Our goal is therefore to enhance transparency by providing researchers with the minimum reporting requirements needed to adequately convey the methods and results of their research.